generics
Cipla Awarded US$189 Million Of Global Fund ARV Tender
Cipla has been selected by the Global Fund to produce anti-retroviral drugs for the next three years.
Amerigen’s Mecobalamin Receives CFDA Approval
The CFDA approval of Mecobalamin marks Amerigen's entry into the Chinese generics market.
Lilly Expands Partnership With China’s Novast
Building on an earlier 2012 agreement, Lilly intends to invest US$60-70 million in Chinese generics manufacturer Novast.
Cipla Gets FDA Approval For Generic HIV Drug
Tentative approval for a generic HIV drug for use outside of the United States has been granted to Indian manufacturer Cipla.
Ranbaxy Fines: More Than Meets The Eye
Indian generics manufacturer Ranbaxy was recently slapped with fines by the U.S. FDA for the manufacturing and distribution of 'adulterated' drugs.
Fujifilm & Dr. Reddy’s Call Off Generic Drugs Joint Venture In Japan
FUJIFILM and Dr. Reddy's Laboratories have terminated an MOU to enter into a joint venture for the Japanese generics drugs market.
Pfizer, Mylan To Team Up On Generics Business In Japan
Pfizer Inc. and Mylan Inc. have signed an agreement to develop, manufacture, distribute, and market generic drugs in Japan.
